(Q47686988)

4 February 2018

title

p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. (English)

1 reference

4 February 2018

author

Regine Schneider-Stock

6

object named as

Regine Schneider-Stock

0 references

Andrzej Semczuk

1

object named as

Andrzej Semczuk

1 reference

4 February 2018

author name string

Carsten Boltze

2

1 reference

4 February 2018

Barbara Marzec

3

1 reference

4 February 2018

Anna Szczygielska

4

1 reference

4 February 2018

Albert Roessner

5

1 reference

4 February 2018

Regine Schneider-Stock

6

1 reference

4 February 2018

publication date

14 August 2003

1 reference

4 February 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

4 February 2018

volume

129

1 reference

4 February 2018

issue

10

1 reference

4 February 2018

page(s)

589-596

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s00432-003-0482-2

exact match

0 references

cites work

Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors

1 reference

12 December 2020

RB protein expression in human endometrial carcinomas--an immunohistochemical study

1 reference

12 December 2020

The tumor suppressor protein p16INK4a.

1 reference

12 December 2020

p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors

1 reference

12 December 2020

Preoperative evaluation and staging of endometrial cancer

1 reference

12 December 2020

Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE

1 reference

12 December 2020

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

12 December 2020

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers

1 reference

12 December 2020

Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines

1 reference

12 December 2020

p16INK4andp15INK4BAlterations in Primary Gynecologic Malignancy

1 reference

12 December 2020

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

1 reference

12 December 2020

Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines

1 reference

12 December 2020

Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis

1 reference

12 December 2020

The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma

1 reference

12 December 2020

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

1 reference

12 December 2020

Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features

1 reference

12 December 2020

K-ras exon 2 point mutations in human endometrial cancer.

1 reference

12 December 2020

High Prognostic Value of p16INK4 Alterations in Gastrointestinal Stromal Tumors

1 reference

12 December 2020

Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.

1 reference

12 December 2020

Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters

1 reference

12 December 2020

Losses of Heterozygosity in Endometrial Adenocarcinomas

1 reference

12 December 2020

Alterations of the p16 (MTS1) gene in testicular, ovarian, and endometrial malignancies

1 reference

12 December 2020

Germline p16 mutations in familial melanoma

1 reference

12 December 2020

Gene alterations at the CDKN2A (p16/MTS1) locus in soft tissue tumors

1 reference

12 December 2020

Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck

1 reference

12 December 2020

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

12 December 2020

Identification of CDK4 sequences involved in cyclin D1 and p16 binding

1 reference

12 December 2020

Mutations and altered expression of p16INK4 in human cancer.

1 reference

12 December 2020

Relationship between p53 pathway and estrogen receptor status in endometrioid-type endometrial cancer

1 reference

12 December 2020

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

1 reference

12 December 2020

Alteration of p16 and p15 genes in human uterine tumours

1 reference

12 December 2020

1 reference

12 December 2020

Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma

1 reference

12 December 2020

Molecular pathology of endometrial hyperplasia and carcinoma

1 reference

12 December 2020

DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis

1 reference

12 December 2020

Theories of endometrial carcinogenesis: a multidisciplinary approach

1 reference

12 December 2020

Immunohistochemical analysis of MIB-1 proliferative activity in human endometrial cancer. Correlation with clinicopathological parameters, patient outcome, retinoblastoma immunoreactivity and K-ras codon 12 point mutations

1 reference

12 December 2020

Alteration of p16 and p15 genes in common epithelial ovarian tumors

1 reference

12 December 2020

Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer

1 reference

12 December 2020

Methylation of p16INK4A in primary gynecologic malignancy

1 reference

12 December 2020

Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis.

1 reference

12 December 2020

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

1 reference

12 December 2020

Low frequency of CDKN2 mutation in endometrial carcinomas

1 reference

12 December 2020

10.1007/S00432-003-0482-2

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

12920579

1 reference

4 February 2018